The effect of anti-PD-1/PD-L1 antibodies combined with VEGF receptor tyrosine kinase inhibitors versus bevacizumab in unresectable hepatocellular carcinoma
暂无分享,去创建一个
J. Ying | Jinyu Wang | Qi Xu | C. Luo | Lei Zhang | Jun Luo | Jingjing Li | Xiaoqing Xu | H. Zeng